¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lymphatic blockade"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® lymphatic system ÇÑ±Û ¸²ÇÁ°è
¼³¸í   
  ´ë°³ ¸Æ°ü°è¶ó°í Çϸé, Ç÷°ü°è¿Í ¸²ÇÁ°ü°è¸¦ ÇÕÃļ­ ¸»ÇÑ´Ù. ÀÌÁß¿¡ ¸²ÇÁ¿¡ ÀÇÇØ ÀÌ·ç¾îÁö´Â ÇϳªÀÇ °èÅëÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blockade
    Â÷´Ü
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü
  • afferent lymphatic vessel
    µé¸²ÇÁ°ü, ¼öÀÔ¸²ÇÁ°ü
  • aggregated lymphatic follicle
    ¹«¸®¸²ÇÁ¼ÒÀý, ÁýÇÕ¸²ÇÁ¼ÒÀý
  • aggregated lymphatic nodule
    ¹«¸®¸²ÇÁ¼ÒÀý
  • capillary-lymphatic malformation
    ¸ð¼¼°ü¸²ÇÁ°ü±âÇü
  • deep cutaneous lymphatic capillary network
    ±íÀºÇǺθ²ÇÁ¸ð¼¼°ü±×¹°, ½ÉºÎÇǺθ²ÇÁ¸ð¼¼°ü¸Á
  • efferent lymphatic vessel
    ³¯¸²ÇÁ°ü, ¼öÃ⸲ÇÁ°ü
  • gut-associated lymphatic tissue
    âÀÚ¿¬°ü¸²ÇÁÁ¶Á÷, À忬°ü¸²ÇÁÁ¶Á÷
  • lymphatic
    1. ¸²ÇÁ°ü- 2. ¸²ÇÁ-
  • lymphatic capillary network
    ¸²ÇÁ¸ð¼¼°ü±×¹°, ¸²ÇÁ¸ð¼¼°ü¸Á
  • lymphatic filariasis
    ¸²ÇÁ»ç»óÃæÁõ
  • lymphatic follicle
    ¸²ÇÁ¼ÒÆ÷
  • lymphatic leukemia
    ¸²ÇÁ¼º¹éÇ÷º´
  • lymphatic network
    ¸²ÇÁ°ü±×¹°, ¸²ÇÁ°ü¸Á
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blockade
    Â÷´Ü
  • major lymphatic drainage
    Áֿ串ÇÁÀ¯Ãâ
  • lymphatic
    ¸²ÇÁ°ü-, ¸²ÇÁ-
  • aggregated lymphatic nodule
    ¹«¸®¸²ÇÁ¼ÒÀý
  • solitary lymphatic nodule
    Ȭ¸²ÇÁ¼ÒÀý
  • lymphatic system
    ¸²ÇÁ°èÅë
  • lymphatic tissue
    ¸²ÇÁÁ¶Á÷
  • afferent lymphatic vessel
    µé¸²ÇÁ°ü
  • lymphatic vessel
    ¸²ÇÁ°ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blockade
    Â÷´Ü
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü
  • afferent lymphatic vessel
    µé¸²ÇÁ°ü
  • aggregated lymphatic follicle
    ¹«¸®¸²ÇÁ¼ÒÀý
  • aggregated lymphatic nodule
    ¹«¸®¸²ÇÁ¼ÒÀý
  • capillary-lymphatic malformation
    ¸ð¼¼Ç÷°ü¸²ÇÁ±âÇü
  • lymphatic cyst
    ¸²ÇÁ³¶, ¸²ÇÁÁÖ¸Ó´Ï
  • deep cutaneous lymphatic capillary network
    ±íÀºÇǺθ²ÇÁ¸ð¼¼°ü±×¹°
  • right lymphatic duct
    ¿À¸¥¸²ÇÁ°ü
  • efferent lymphatic vessel
    ³¯¸²ÇÁ°ü
  • lymphatic filariasis
    ¸²ÇÁ»ç»óÃæÁõ
  • lymphatic follicle
    ¸²ÇÁ¼ÒÀý
  • solitary lymphatic follicle
    Ȭ¸²ÇÁ¼ÒÀý
  • gut-associated lymphatic tissue
    âÀÚ¿¬°ü¸²ÇÁÁ¶Á÷
  • lymphatic
    ¸²ÇÁ°ü-, ¸²ÇÁ-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MAC-BAR(minimum alveolar concentration-blockade of autonomic response)
    ÀÚÀ²½Å°æ¾ïÁ¦ ÃÖ¼ÒÆóÆ÷³»³óµµ
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü<ºÀ¼â>(¡­ó´Ó¨<Üæáð>).
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü(¡­ó´Ó¨).
  • receptor blockade
    ¼ö¿ëüÂ÷´Ü
  • renal blockade
    ½ÅÂ÷´Ü(ãìó´Ó¨).
  • Lymphatic circulation
    ¸²ÇÁ¼øÈ¯(¡­âàü»)
  • Lymphatic system
    ¸²ÇÁ°è(¡­Í£)
  • afferent lymphatic vessel
    µé¸²ÇÁ°ü
  • aggregated lymphatic follicles
    ¹«¸®¸²ÇÁ¼ÒÀý
  • aggregated lymphatic follicles of vermiform appendix
    ¸·Ã¢ÀÚ²¿¸®¸²ÇÁ¼ÒÀý
  • aggregated lymphatic nodule
    ¹«¸®¸²ÇÁ¼ÒÀý
  • aggregated lymphatic nodules
    ¹æ»ç ¹«¸®¸²ÇÁ¼ÒÀý, ÁýÇÕ(ó¢ùê)¸²ÇÁ¼ÒÀý.
  • aggregated lymphatic nodules of vermiform appendi
    ¹æ»ç Ãæ¼ö¹«¸®¸²ÇÁ¼ÒÀý, Ãæ¼öÁýÇÕ(õùá÷ó¢ùê
  • gut-associated lymphatic tissue (GALT)
    Àå-¿¬°ü ¸²ÇÁÁ¶Á÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphatic blockade
    ¸²ÇÁ·ùÂ÷´Ü.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • block/blockade
    Â÷´Ü.
  • blockade
    ºÀ¼â, Â÷´Ü, ºÀ¼âÁ¦, Â÷´ÜÁ¦.
  • blockade narcotic
    ¸¶¾à¼º Â÷´Ü.
  • differential blockade
    °¨º°Â÷´Ü.
  • effector-cell blockade
    ÀÛµ¿¼¼Æ÷Â÷´Ü
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü<ºÀ¼â>(¡­ó´Ó¨<Üæáð>).
  • ganglionic blockade
    ½Å°æÀýÂ÷´Ü(¡­ó´Ó¨).
  • myoneural blockade
    ½Å°æ±ÙÂ÷´Ü(ãêÌèÐÉó´Ó¨).
  • narcotic blockade
    ¸¶¾à¼º Â÷´Ü<ºÀ¼â>.
  • narcotic blockade
    ¸¶¾à¼º Â÷´Ü.
  • nondepolarizing neuromuscular blockade
    ºñÅ»ºÐ±Ø¼º ½Å°æ±ÙÂ÷´Ü
  • occipital nerve blockade
    ÈĵνŰæÂ÷´Ü
  • paravertebral blockade
    ôÃßÁÖÀ§Â÷´Ü.
  • receptor blockade
    ¼ö¿ëüÂ÷´Ü
  • renal blockade
    ½ÅÂ÷´Ü(ãìó´Ó¨).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • (Lymphatic ring of cardiac portion)
    (µé¹®¸²ÇÁÀý°í¸®)
    [¿¾ ¿ë¾î] ºÐ¹®ÀÓÆÄÀý°í¸®
  • Axillary lymphatic plexus
    °Üµå¶û¸²ÇÁ°ü¾ó±â
    [¿¾ ¿ë¾î] ¾×¿ÍÀÓÆÄÃÑ
  • Muscular type of lymphatic vessel
    ±ÙÀ°Çü¸²ÇÁ°ü
    [¿¾ ¿ë¾î] ±ÙÇüÀӯİü
  • Tracheal lymphatic nodules
    ±â°ü¸²ÇÁ¼ÒÀý
    [¿¾ ¿ë¾î] ±â°üÀӯļÒÀý
  • Bronchial lymphatic nodules
    ±â°üÁö¸²ÇÁ¼ÒÀý
    [¿¾ ¿ë¾î] ±â°üÁöÀӯļÒÀý
  • Deep lymphatic vessel
    ±íÀº¸²ÇÁ°ü
    [¿¾ ¿ë¾î] ½ÉÀӯİü
  • Deep cutaneous lymphatic capillary network
    ±íÀºÇǺθ²ÇÁ¸ð¼¼°ü±×¹°
    [¿¾ ¿ë¾î] ½ÉÇǺθð¼¼Àӯİü¸Á
  • Efferent lymphatic vessel
    ³¯¸²ÇÁ°ü
    [¿¾ ¿ë¾î] ¼öÃâÀӯİü
  • Periarterial lymphatic sheath
    µ¿¸ÆÁÖÀ§¸²ÇÁ±¸Áý
    [¿¾ ¿ë¾î] µ¿¸ÆÁÖÀ§ÀÓÆÄÃÊ
  • Afferent lymphatic vessel
    µé¸²ÇÁ°ü
    [¿¾ ¿ë¾î] ¼öÀÔÀӯİü
  • Lymphatic duct
    ¸²ÇÁ°ü
    [¿¾ ¿ë¾î] Àӯİü
  • Lymphatic vessel
    ¸²ÇÁ°ü
    [¿¾ ¿ë¾î] Àӯİü
  • lymphatic vessls
    ¸²ÇÁ°ü
    [¿¾ ¿ë¾î] Àӯİü
  • Lymphatic plexus
    ¸²ÇÁ°ü¾ó±â
    [¿¾ ¿ë¾î] ÀӯİüÃÑ
  • Lymphatic trunk
    ¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] ÀÓÆÄº»°£
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphatic filariasis
    ¸²ÇÁ»ç»óÃæÁõ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blockade
    ºÀ¼â, Â÷´Ü, ºÀ¼âÁ¦, Â÷´ÜÁ¦
  • lymphatic
    ¸²ÇÁ°üÀÇ, ¸²ÇÁÀÇ
  • lymphatic duct
    ¸²ÇÁ°ü
  • lymphatic system
    ¸²ÇÁ°è
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BB bad breath; bed bath; beta blockade, beta blocker; BioBreeding [rat]; blanket bath; blood bank; bloo...
NMB neuromedin B; neuromuscular blockade; neuromuscular blocking; neuromuscular blocker/blocking [drug, ...
BLS bare lymphocyte syndrome; basic life support; blind loop syndrome; blood and lymphatic system; blood...
CLL cholesterol-lowering lipid; chronic lymphatic leukemia; chronic lymphocytic leukemia; cow lung lavag...
LCM latent cardiomyopathy; left costal margin; leukocyte-conditioned medium; lowest common multiple; lym...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ALL Acute Lymphatic Leukemia
CLL Chronic Lymphatic Leukaemia
CAB Combined androgen blockade
MAB Maximal androgen blockade
NMB Neuromuscular blockade
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blockade
    ºÀ¼â, Â÷´Ü
    1. Ä«¸£¹ÎÀ̳ª ź¼Ò ÀÔÀÚ¿Í °°Àº ¹«ÇØÇÑ ¹°ÁúÀ» Á¤¸Æ³»·Î ÁÖÀÔÇÏ¿© »ýü³» ¼¼¸Á ³»ÇǼ¼Æ÷ÀÇ ½ÄÀÛ¿ëÀ» ÀúÇϽÃŰ´Â °Í. 2. ¾à¹°·Î »ý¸®Àû ¶Ç´Â È¿¼Ò ÀÛ¿ëÀ» ÀúÁöÇÏ´Â °Í. 3. ¾à¹°·Î ´Ù¸¥ ¾à¹°ÀÇ È¿·ÂÀ» ÀúÁöÇÏ´Â °Í. ¿¹ÄÁ´ë Çì·ÎÀÎ ÀÛ¿ë¿¡ ´ëÇÑ ³¯·ÎÇÉÀÇ ¾ïÁ¦ ÀÛ¿ë. 4. Â÷´Ü¾à, ºÀ¼â¾à.
  • myoneural blockade
    ½Å°æ±Ù Â÷´Ü
  • narcotic blockade
    ¸¶¾à¼º Â÷´Ü
  • neurolytic blockade
    ½Å°æ ¿ëÇØ¼º Â÷´Ü
  • paravertebral blockade
    ôÃß ÁÖÀ§ Â÷´Ü
  • selective local anesthetic blockade
    ¼±ÅÃÀûÀÎ ±¹¼Ò ¸¶Ãë
  • afferent lymphatic vessel
    ¼öÀÔ ¸²ÇÁ°ü
    1. ¸²ÇÁÀý·Î µé¾î°¡´Â ¸²ÇÁ°üÀ» ¸»Çϸç, ¸²ÇÁÀýÀÇ º¼·Ï¸é¿¡¼­ ¿©·¯ °³°¡ À¯ÀÔÇÏ´Â °ÍÀÌ ÀϹÝÀûÀÌ´Ù. 2. Á¶Á÷¿¡¼­ ½º¸ç³ª¿Â ¸²ÇÁ´Â ¿©·¯ °³ÀÇ ¼öÀÔ ¸²ÇÁ°üÀ» ÅëÇÏ¿© ¸²ÇÁÀý¿¡ µé¾î°¡°í, ¼öÃâ ¸²ÇÁ°ü
  • aggregated lymphatic follicles of vermiform appendix
    ¸·Ã¢ÀÚ ²¿¸® ¸²ÇÁ ¼ÒÀý
    ´ëÀåÀÇ Á¡¸· °íÀ¯Ãþ¿¡´Â °í¸³ ¸²ÇÁ ¼ÒÀýÀÌ ´Ù¼ö »êÀçÇϰí ÀÖ´Ù. ±×·¯³ª Ãæ¼ö¿¡¼­´Â ƯÈ÷ Áý´ÜÀ» ÀÌ·ç°í ¸²ÇÁ Á¶Á÷¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÏÁ¾ÀÇ ÁýÇÕ ¸²ÇÁ ¼ÒÀýÀÌ ÀüÃþÀ» Ãæ¸¸Çϰí ÀÖ´Ù. À̵éÀÇ Á¶Á÷ ÇüÅ´ ÀεΠÆíµµ³ª, ¼³ Æíµµ¿Í ºñ½ÁÇϰí, º¹ºÎ Æíµµ·Î ¸í¸íµÇ´Â °æ¿ìµµ ÀÖ´Ù.
  • central lymphatic organ
    ÁßÃß ÀÓÆÄ°è ±â°ü, ÁßÃß ¸²ÇÁ Á¶Á÷ Àå±â
    Ç×ü »ý»ê ¹× ¼¼Æ÷ ¸é¿ª¿¡ °ü¿©ÇÏ´Â ¸é¿ª Á¶Á÷ Áß¿¡¼­ °£ ¼¼Æ÷·ÎºÎÅÍ ¸é¿ª Ȱ¼º ¼¼Æ÷·ÎÀÇ ºÐÈ­ÀÇ Àå¼Ò°¡ µÇ´Â ¸²ÇÁ Á¶Á÷À» ÁßÃß ¸²ÇÁ Á¶Á÷À̶ó°í ºÎ¸¥´Ù. À̰Ϳ¡´Â Èä¼±, Á¶·ù¿¡¼­´Â Fabricius³¶, Æ÷À¯·ù¿¡¼­´Â À̰Ͱú À¯»çÇÑ Á¶Á÷ÀÌ Æ÷ÇԵȴÙ.
  • left lumbar lymphatic trunk
    ¿Þ Ç㸮 ¸²ÇÁ°ü ÁÙ±â
  • lymphatic capillary network
    ¸²ÇÁ ¸ð¼¼°ü¸Á
  • lymphatic drainage
    ¸²ÇÁ¹è¾×, Àӯİü ¹è³ó
  • lymphatic leukemia
    Àӯļº ¹éÇ÷º´
  • lymphatic system
    ¸²ÇÁ°è
    °¨¿°À̳ª Áúº´°ú ½Î¿ì´Â ¼¼Æ÷¸¦ ¸¸µé°Å³ª ÀúÀåÇÏ´Â Á¶Á÷°ú Àå±â. °ñ¼ö, ºñÀå, Èä¼±, ±×¸®°í ¸²ÇÁÀý µîÀÌ ¸²ÇÁ°èÀÇ ´ëÇ¥Àû Àå±âÀÌ´Ù. ¸²ÇÁ°è¿¡´Â ÀÌ·¯ÇÑ ¿©·¯ Á¶Á÷°ú Àå±â¸¦ ¿¬°áÇÏ´Â Åë·Î Áï ¸²ÇÁ°üÀÌ ÀÖÀ¸¸ç À̸¦ ÅëÇØ ¸²ÇÁ°¡ ¿î¹ÝµÈ´Ù.
  • lymphatic tissue
    ÀÓÆÄ Á¶Á÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adrenergic blockade Selective inhibition by a drug of the responses of effector cells to adrenergic sympathetic nerve impulses (sympatholytic) and to epinephrine and related amines (adrenolytic).
(05 Mar 2000)
blockade 1. Intravenous injection of large amounts of colloidal dyes or other substances whereby the reaction of the reticuloendothelial cells to other influences (e.g., by phagocytosis) is temporarily prevented.
2. Arrest of peripheral nerve conduction or transmission at autonomic synaptic junctions, autonomic receptor sites, or myoneural junctions by a drug.
(05 Mar 2000)
ganglionic blockade Inhibition of nerve impulse transmission at autonomic ganglionic synapses by drugs such as nicotine or hexamethonium.
(05 Mar 2000)
virus blockade The interference of one virus by another, either attenuated or unrelated.
(05 Mar 2000)
cholinergic blockade Inhibition by a drug of nerve impulse transmission at autonomic ganglionic synapses (ganglionic blockade), at postganglionic parasympathetic effector cells (e.g., by atropine), and at myoneural junctions (myoneural blockade), the inhibition of a cholinergic agent.
(05 Mar 2000)
myoneural blockade Inhibition of nerve impulse transmission at myoneural junctions by a drug such as curare.
(05 Mar 2000)
narcotic blockade The use of drugs to inhibit the effects of narcotic substances, as with naloxone.
(05 Mar 2000)
neuromuscular blockade The intentional interruption of transmission at the neuromuscular junction by external agents, usually neuromuscular blocking agents. It is distinguished from nerve block in which nerve conduction is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce muscle relaxation as an adjunct to anaesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anaesthesia but is grouped here with anaesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here.
(12 Dec 1998)
sympathetic blockade Interruption of transmission in sympathetic ganglia or conduction of impulses in pre-or postganglionic sympathetic nerve fibres.
(05 Mar 2000)
afferent lymphatic A lymphatic vessel entering, or bringing lymph to, a node.
Synonym: vas lymphaticum afferens, afferent vessel.
(05 Mar 2000)
aggregated lymphatic follicles Lymphoid organs located in the sub mucosal tissue of the mammalian gut containing very high proportions of IgA secreting precursor cells. The patches have B and T dependent regions and germinal centres. A specialised epithelium lies between the patch and the intestine. Involved in gut associated immunity.
(18 Nov 1997)
aggregated lymphatic follicles of vermiform appendix Masses of lymphoid tissue in the submucous coat of the vermiform appendix.
Synonym: folliculi lymphatici aggregati appendicis vermiformis.
(05 Mar 2000)
aggregated lymphatic nodules Lymphoid organs located in the sub mucosal tissue of the mammalian gut containing very high proportions of IgA secreting precursor cells. The patches have B and T dependent regions and germinal centres. A specialised epithelium lies between the patch and the intestine. Involved in gut associated immunity.
(18 Nov 1997)
aortic lymphatic plexus A plexus of lymph nodes and connecting vessels lying along the lower portion of the abdominal aorta.
Synonym: plexus aorticus.
(05 Mar 2000)
cardiac lymphatic ring A group of lymph nodes surrounding the cardia of the stomach.
Synonym: annulus lymphaticus cardiae, cardiac lymphatic ring.
(05 Mar 2000)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
lymphatic blockade A local defense mechanism in which minute bits of material, such as fibrinous exudate from injured tissue, enter local lymphatic vessels, obstructing them and preventing foreign substances, esp. bacteria, from passing through
Ãâó:
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lymphatic
    ÀÓÆÄÀÇ
  • lymphatic
    Àӯľ×ÀÇ;¿¬¾àÇÑ;(¼ºÁúÀÌ) ±À¶á
  • blockade
    ºÀ¼â
  • blockade
    ºÀ¼â;Æó¼â;±³ÅëÂ÷´Ü;°æÁ¦ºÀ¼â
  • economic blockade
    °æÁ¦ ºÀ¼â
  • food blockade
    ½Ä·®ºÀ¼â
  • pacific blockade
    Æò½Ã ºÀ¼â
  • paper blockade
    (¼±¾ð¿¡ ±×Ä¡´Â)Áö»óºÀ¼â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á